CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on February 13, 2008
Clin J Am Soc Nephrol 3: 706-713, 2008
© 2008 American Society of Nephrology
doi: 10.2215/CJN.04271007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.04271007v1
3/3/706    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosolowsky, E. T.
Right arrow Articles by Krolewski, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosolowsky, E. T.
Right arrow Articles by Krolewski, A. S.

Diabetes and the Kidney

High-Normal Serum Uric Acid Is Associated with Impaired Glomerular Filtration Rate in Nonproteinuric Patients with Type 1 Diabetes

Elizabeth T. Rosolowsky*,{dagger}, Linda H. Ficociello*, Nicholas J. Maselli*, Monika A. Niewczas*,{ddagger}, Amanda L. Binns*, Bijan Roshan*, James H. Warram*, and Andrzej S. Krolewski*,{ddagger}

* Research Division, Joslin Diabetes Center, {dagger} Division of Endocrinology at Children's Hospital Boston, and {ddagger} Department of Medicine at Brigham and Women Hospital, Harvard Medical School, Boston, Massachusetts

Correspondence: Dr. Andrzej S. Krolewski, Section on Genetics & Epidemiology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215. Phone: 617-732-2668; Fax: 617-732-2667; E-mail: Andrzej.Krolewski{at}joslin.harvard.edu

Background and objectives: Early renal function decline begins before the onset of proteinuria in patients with type 1 diabetes. The association of elevated serum uric acid with advanced impaired renal function prompts an examination of its role in early renal function decline in patients before proteinuria develops.

Design, setting, participants, & measurements: Patients with type 1 diabetes and normoalbuminuria or microalbuminuria were recruited to the Second Joslin Kidney Study. A medical history and measurements of BP, hemoglobin A1c, albumin excretion rate, and serum concentrations of uric acid and cystatin C were obtained. Estimated glomerular filtration rate was measured by a cystatin C–based formula.

Results: We studied 364 patients with normoalbuminuria and 311 patients with microalbuminuria. Mean glomerular filtration rate in these groups was 119 and 99 ml/min, respectively. Mildly or moderately impaired renal function (<90 ml/min) was present in 10% of those with normoalbuminuria and 36% of those with microalbuminuria. In univariate and multivariate analyses, lower glomerular filtration rate was strongly and independently associated with higher serum uric acid and higher urinary albumin excretion rate, older age, and antihypertensive treatment.

Conclusions: Serum uric acid concentration in the high-normal range is associated with impaired renal function in patients with type 1 diabetes. Follow-up studies are needed to confirm that this level of serum uric acid is a risk factor for early renal function decline in type 1 diabetes and to determine whether its reduction would prevent the decline.




This article has been cited by other articles:


Home page
Diabetes CareHome page
G. Zoppini, G. Targher, C. Negri, V. Stoico, F. Perrone, M. Muggeo, and E. Bonora
Elevated Serum Uric Acid Concentrations Independently Predict Cardiovascular Mortality in Type 2 Diabetic Patients
Diabetes Care, September 1, 2009; 32(9): 1716 - 1720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Kosugi, T. Nakayama, M. Heinig, L. Zhang, Y. Yuzawa, L. G. Sanchez-Lozada, C. Roncal, R. J. Johnson, and T. Nakagawa
Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice
Am J Physiol Renal Physiol, August 1, 2009; 297(2): F481 - F488.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Hovind, P. Rossing, L. Tarnow, R. J. Johnson, and H.-H. Parving
Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study
Diabetes, July 1, 2009; 58(7): 1668 - 1671.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin, J. Manitius, L. G. Sanchez-Lozada, D. I. Feig, M. Shafiu, M. Segal, R. J. Glassock, M. Shimada, et al.
Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?
Endocr. Rev., February 1, 2009; 30(1): 96 - 116.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. I. Feig, D.-H. Kang, and R. J. Johnson
Uric Acid and Cardiovascular Risk
N. Engl. J. Med., October 23, 2008; 359(17): 1811 - 1821.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. T. Le, M. Shafiu, W. Mu, and R. J. Johnson
SLC2A9--a fructose transporter identified as a novel uric acid transporter
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2746 - 2749.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Nephrology.